A Linear Dose-Response Relationship between Fasting Plasma Glucose and Colorectal Cancer Risk: Systematic Review and Meta-analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Shi, Jianguo ^a   Xiong, Lijuan ^a   Li, Jiaoyuan ^a   Cao, Heng ^a   Jiang, Wen ^a   Liu, Bo ^a   Chen, Xueqin ^a   Liu, Cheng ^a   Liu, Ke ^a   Wang, Guobin ^a   Cai, Kailin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE BLOOD LEVEL;

BLOOD; COLON TUMOR; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; META ANALYSIS; METABOLISM; RECTUM TUMOR; RISK FACTOR;

BLOOD GLUCOSE; COLONIC NEOPLASMS; FASTING; FEMALE; HUMANS; MALE; RECTAL NEOPLASMS; RISK FACTORS;

EID: 84948962679     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17591     Document Type: Review

References (58)

1. Hjartaker, A. et al. Subsite-specific dietary risk factors for colorectal cancer: a review of cohort studies. J Oncol 2013, Article ID 703854, 14 pages (2013).
2. Theodoratou, E. et al. Associations between dietary and lifestyle risk factors and colorectal cancer in the Scottish population. Eur J Cancer Prev 23, 8-17 (2014).
3. Rasool, S., Kadla, S. A., Rasool, V. & Ganai, B. A. A comparative overview of general risk factors associated with the incidence of colorectal cancer. Tumor Biol 34, 2469-2476 (2013).
4. Raskov, H., Pommergaard, H. C., Burcharth, J. & Rosenberg, J. Colorectal carcinogenesis-update and perspectives. World J Gastroentero 20, 18151-18164 (2014).
5. Zhu, B., Zou, L., Qi, L., Zhong, R. & Miao, X. Allium vegetables and garlic supplements do not reduce risk of colorectal cancer, based on meta-analysis of prospective studies. Clin Gastroenterol Hepatol 12, 1991-2001 (2014).
6. Cai, X. et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia 57, 2261-2269 (2014).
7. Esposito, K. et al. Colorectal cancer association with metabolic syndrome and its components: A systematic review with metaanalysis. Endocrine 44, 634-647 (2013).
8. De Bruijn, K. M. J. et al. Detection bias may be the main cause of increased cancer incidence among diabetics: Results from the Rotterdam study. Eur J Cancer 50, 2449-2455 (2014).
9. Larsson, S. C., Orsini, N. & Wolk, A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97, 1679-1687 (2005).
10. Seshasai, S. R. K. et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. New Engl J Med 364, 829-841 (2011).
11. Tao, Z., Shi, A. & Zhao, J. Epidemiological Perspectives of Diabetes. Cell Biochem Biophys (2015); doi: 10.1007/s12013-015-0598-4.
12. Ostovaneh, M. R. et al. Prevalence of metabolic syndrome in Amol and Zahedan, Iran: a population based study. Arch Iran Med 17, 477-482 (2014).
13. Liu, X. et al. Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese. Diabetologia 57, 1834-1841 (2014).
14. Heiss, G. et al. Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic Community Health Study/Study of Latinos. Diabetes Care 37, 2391-2399 (2014).
15. American Diabetes, A. (2) Classification and diagnosis of diabetes. Diabetes Care 38, S8-S16 (2015).
16. Guariguata, L., Whiting, D. R., Linnenkamp, U., Beagley, J. & Shaw, J. Global estimates of the prevalence of impaired glucose tolerance for 2013 and projections to 2035. Diabetes 63, A391 (2014).
17. Xu, C. X., Zhu, H. H. & Zhu, Y. M. Diabetes and cancer: Associations, mechanisms, and implications for medical practice. World J Diabetes 5, 372-380 (2014).
18. Gallagher, E. J. & Leroith, D. Diabetes, antihyperglycemic medications and cancer risk: Smoke or fire? Curr Opin Endocrinol 20, 485-494 (2013).
19. Siddiqui, A. A. Metabolic syndrome and its association with colorectal cancer: A review. Am J Med Sci. 341, 227-231 (2011).
20. Evans, J. L., Goldfine, I. D., Maddux, B. A. & Grodsky, G. M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 23, 599-622 (2002).
21. Kim, M. K., Sasaki, S., Otani, T. & Tsugane, S. Dietary patterns and subsequent colorectal cancer risk by subsite: a prospective cohort study. Int J Cancer 115, 790-798 (2005).
22. Schoen, R. E. et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst. 91, 1147-1154 (1999).
23. Jee, S. H. et al. Fasting serum glucose level and cancer risk in Korean men and women. Jama 293, 194-202 (2005).
24. Limburg, P. J. et al. Insulin, Glucose, Insulin Resistance, and Incident Colorectal Cancer in Male Smokers. Clin Gastroenterol H 4, 1514-1521 (2006).
25. Stocks, T. et al. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer 117, 2398-2407 (2011).
26. Kabat, G. C. et al. A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women. Brit J Cancer 106, 227-232 (2012).
27. Wulaningsih, W. et al. Serum lipids and the risk of gastrointestinal malignancies in the swedish AMORIS study. Journal of Cancer Epidemiology 2012, Article ID 792034, 10 pages, (2012).
28. Currie, C. J., Poole, C. D. & Gale, E. A. M. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52, 1766-1777 (2009).
29. Hsieh, M. C. et al. The Influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res (2012); doi: 10.1155/2012/413782.
30. Orsini, N., Li, R., Wolk, A., Khudyakov, P. & Spiegelman, D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175, 66-73 (2012).
31. Higgins, J. & Green, S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: http://handbook.cochrane.org/. Accessed: 08/04/2015
32. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283, 2008-2012 (2000).
33. Wells, G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2011). Available at: www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed: 26/03/2015.
34. Greenland, S. & Longnecker, M. P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135, 1301-1309 (1992).
35. Orsini, N., Bellocco, R. & Greenland, S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 6, 40-57 (2006).
36. Smith, P. L. Splines as a Useful and Convenient Statistical Tool. Am Stat 33, 57-62 (1979).
37. Cryer P. E. & Davis S. N. Hypoglycemia. In Harrison's Principles of Internal Medicine 18nd edn (eds Longo D. L. et al.) Ch. 345, (McGraw-Hill, 2012).
38. Platz, E. A. et al. Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Cause Control 10, 379-386 (1999).
39. Saydah, S. H. et al. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidem Biomar 12, 412-418 (2003).
40. Stocks, T. et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obesity 32, 304-314 (2008).
41. Rinaldi, S. et al. Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer Epidem Biomar 17, 3108-3115 (2008).
42. Ozasa, K. et al. Glucose intolerance and colorectal cancer risk in a nested case-control study among Japanese people. J Epidemiol 15, S180-S184 (2005).
43. Nilsen, T. L. & Vatten, L. J. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: Exploring the hyperinsulinaemia hypothesis. Brit J Cancer 84, 417-422 (2001).
44. Ahmed, R. L., Schmitz, K. H., Anderson, K. E., Rosamond, W. D. & Folsom, A. R. The metabolic syndrome and risk of incident colorectal cancer. Cancer 107, 28-36 (2006).
45. Shin, A. et al. Site-specific risk factors for colorectal cancer in a Korean population. PLoS One 6, e23196 (2011).
46. Aleksandrova, K. et al. Metabolic syndrome and risks of colon and rectal cancer: The european prospective investigation into cancer and nutrition study. Cancer Prev Res 4, 1873-1883 (2011).
47. Shin, H. Y., Jung, K. J., Linton, J. A. & Jee, S. H. Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men: The Korean Cancer Prevention Study-II. Metabolism: Clinical and Experimental 63, 1250-1256 (2014).
48. Deng, L., Gui, Z., Zhao, L., Wang, J. & Shen, L. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Digest Dis Sci 57, 1576-1585 (2012).
49. Handelsman, Y. et al. Diabetes and cancer-an AACE/ACE consensus statement. Endocri Pract 19, 675-693 (2013).
50. Lorenzi, M., Montisano, D. F., Toledo, S. & Barrieux, A. High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest 77, 322-325 (1986).
51. Laporte, D. et al. Metabolic status rather than cell cycle signals control quiescence entry and exit. J Cell Biol 192, 949-957 (2011).
52. Anagnostou, S. H. & Shepherd, P. R. Glucose induces an autocrine activation of the Wnt/beta-catenin pathway in macrophage cell lines. Biochem J 416, 211-218 (2008).
53. Chocarro-Calvo, A., Garcia-Martinez, J. M., Ardila-Gonzalez, S., De la Vieja, A. & Garcia-Jimenez, C. Glucose-induced betacatenin acetylation enhances Wnt signaling in cancer. Mol Cell 49, 474-486 (2013).
54. Lin, C. Y. et al. Impact of high glucose on metastasis of colon cancer cells. World J Gastroentero 21, 2047-2057 (2015).
55. Morgan, R. G. et al. Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells. Brit J Cancer 112, 714-719 (2015).
56. Ren, X. et al. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China. Public Health 123, 540-544 (2009).
57. Geier, A. S. et al. Cancer detection rates following enrolment in a disease management programme for type 2 diabetes. Diabetologia 56, 1944-1948 (2013).
58. Parekh, N., Lin, Y., Vadiveloo, M., Hayes, R. B. & Lu-Yao, G. L. Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham heart study-offspring cohort (1971-2008). Cancer Epidem Biomar 22, 1825-1836 (2013).